* PetIQ Inc PETQ.OQ reported a quarterly adjusted loss
of 12
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -10
cents. The mean expectation of five analysts for the quarter
was for a loss of 29 cents per share. Wall Street expected
results to range from -44 cents to -20 cents per share.
* Revenue rose 19.5% to $219.93 million from a year ago;
analysts
expected $189.05 million.
* PetIQ Inc's reported EPS for the quarter was a loss of 60
cents.
* The company reported a quarterly loss of $17.49 million.
* PetIQ Inc shares had fallen by 5.5% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 4.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for PetIQ Inc is
$28.00
This summary was machine generated from LSEG data February 29 at
12:01 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.29 -0.12 Beat
Sep. 30 2023 0.02 0.42 Beat
Jun. 30 2023 0.26 0.46 Beat
Mar. 31 2023 0.35 0.45 Beat